Five Prime Therapeutics Inc Revenue Growth Rates (FPRX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Five Prime Therapeutics Inc   (NASDAQ: FPRX)
 

FPRX's Revenue Growth by Quarter and Year

Five Prime Therapeutics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FPRX Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December -0.71
3rd Quarter September 2.05
2nd Quarter June 3.42
1st Quarter March 8.41
FY 13.17

FPRXs Annual Revenue
Five Prime Therapeutics Inc 's Revenue in the fiscal year 2020 $ 13.18 millions
Five Prime Therapeutics Inc 's Revenue in the fiscal year 2019 $ 14.87 millions
Five Prime Therapeutics Inc 's Revenue in the fiscal year 2018 $ 49.87 millions
Five Prime Therapeutics Inc 's Revenue in the fiscal year 2017 $ 39.51 millions
Five Prime Therapeutics Inc 's Revenue in the fiscal year 2016 $ 30.69 millions




FPRX Revenue fourth quarter 2020 Y/Y Growth Comment
Five Prime Therapeutics Inc in the fourth quarter 2020 recorded of $ -0.71 millions.

Looking into fourth quarter 2020 results within Major Pharmaceutical Preparations industry 129 other companies have achieved higher Revenue growth. While Five Prime Therapeutics Inc ' s Revenue meltdown of -122.06% ranks overall at the positon no. 1871 in the fourth quarter 2020.


FPRX Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter December - -20.35 % -69.52 % 60.05 %
3rd Quarter September -31.21 % -48.35 % -30.73 % 24.7 %
2nd Quarter June 2.7 % -56.07 % -3.07 % -15.28 %
1st Quarter March 57.2 % -83.53 % 220.41 % 55.52 %
FY   -11.42 % -70.18 % 26.22 % -

Financial Statements
Five Prime Therapeutics Inc 's fourth quarter 2020 Revenue $ -0.71 millions FPRX's Income Statement
Five Prime Therapeutics Inc 's fourth quarter 2019 Revenue $ 3.21 millions Quarterly FPRX's Income Statement


FPRX Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter December - 7.72 % -30.16 % 58.7 %
3rd Quarter September -40.06 % -10.51 % -23.88 % 6.52 %
2nd Quarter June -59.33 % -37.76 % -76.67 % -22.88 %
1st Quarter March 161.99 % 32.75 % 145.76 % 22.76 %
FY (Year on Year)   -11.42 % -70.18 % 26.22 % -


Back to FPRX Growth rate Comparisons >> Back to FPRX Growth rate Comparisons >>


Revenue fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #130
Healthcare Sector #297
Overall #1871

Revenue Y/Y Growth Statistics
High Average Low
1874.94 % 300.19 % -90.81 %
(Dec 31 2015)   (Sep 30 2017)
Revenue fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #130
Healthcare Sector #297
Overall #1871
Revenue Y/Y Growth Statistics
High Average Low
1874.94 % 300.19 % -90.81 %
(Dec 31 2015)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Five Prime Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FPRX's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of -0.71 millions by Five Prime Therapeutics Inc come out even worse considering the 2.05 millions a quarter before.

Within Major Pharmaceutical Preparations industry Five Prime Therapeutics Inc achieved highest sequential Revenue growth. While Five Prime Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FPRX's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of -0.71 millions by Five Prime Therapeutics Inc come out even worse considering the 2.05 millions a quarter before.

Within Major Pharmaceutical Preparations industry Five Prime Therapeutics Inc achieved highest sequential Revenue growth. While Five Prime Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is .


Five Prime Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)
Cumulative Revenue 12 Months Ending $ 13.18 $ 17.10 $ 18.03 $ 17.94 $ 14.87
Y / Y Revenue Growth (TTM) -11.4 % 8.93 % -2.43 % -21.07 % -70.17 %
Year on Year Revenue Growth Overall Ranking # 3691 # 289 # 1543 # 1334 # 1811
Seqeuential Revenue Change (TTM) -22.92 % -5.19 % 0.51 % 20.62 % -5.23 %
Seq. Revenue Growth (TTM) Overall Ranking # 1868 # 1312 # 1124 # 134 # 1209


Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2020 Five Prime Therapeutics Inc reported a decline in Revenue by -11.4% year on year, to $13 millions, compare to the 8.93% growth at Sep 30 2020.

In the Healthcare sector 487 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 289 to 3691.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 130
Healthcare Sector # 488
Overall # 3691

Revenue TTM Y/Y Growth Statistics
High Average Low
1874.94 %
 300.19 %
-90.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 130
Sector # 297
S&P 500 # 1868
Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2020 Five Prime Therapeutics Inc reported a decline in Revenue by -11.4% year on year, to $13 millions, compare to the 8.93% growth at Sep 30 2020.

In the Healthcare sector 487 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 289 to 3691.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 130
Healthcare Sector # 488
Overall # 3691

Revenue TTM Y/Y Growth Statistics
High Average Low
1874.94 %
300.19 %
-90.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 130
Sector # 297
S&P 500 # 1868




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FPRX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2020
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Orthopediatrics Corp-0.15%$ -0.148 millions
Precision Optics Corporation Inc -0.40%$ -0.404 millions
Bausch Health Companies Inc -0.49%$ -0.495 millions
Biomarin Pharmaceutical Inc-0.51%$ -0.512 millions
Endo International Plc-0.60%$ -0.599 millions
Sanofi-0.70%$ -0.696 millions
Stereotaxis Inc -0.99%$ -0.987 millions
Prestige Consumer Healthcare Inc -1.14%$ -1.144 millions
Accuray Incorporated-1.38%$ -1.383 millions
Surmodics Inc -1.41%$ -1.411 millions
Integra Lifesciences Holdings Corp-1.64%$ -1.640 millions
Nanostring Technologies Inc -1.81%$ -1.811 millions
Zimmer Biomet Holdings Inc -1.90%$ -1.901 millions
Castle Biosciences Inc -1.90%$ -1.903 millions
Rockwell Medical inc -2.10%$ -2.103 millions
Delcath Systems Inc -2.12%$ -2.124 millions
Vystar Corporation-2.13%$ -2.131 millions
U S Physical Therapy Inc-2.17%$ -2.165 millions
Sientra Inc -2.44%$ -2.439 millions
Corcept Therapeutics Inc-2.46%$ -2.457 millions
Perrigo Company Plc-2.52%$ -2.517 millions
Avanos Medical Inc -2.53%$ -2.529 millions
Arcus Biosciences Inc -2.70%$ -2.697 millions
Pacific Biosciences Of California Inc -2.84%$ -2.843 millions
Orthofix Medical Inc -3.19%$ -3.189 millions
Dentsply Sirona Inc -3.19%$ -3.194 millions
Cutera Inc -3.58%$ -3.576 millions
Lifevantage Corp-3.65%$ -3.649 millions
Phibro Animal Health Corporation-3.67%$ -3.674 millions


About Five Prime Therapeutics Inc Revenue Growth Rates (FPRX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.